Australia's largest stock trading and investment forum Australia's #1 stock forum

VLA

Click for more information

0.00%

$1.75 viralytics limited

IDO1/Keytruda combo trial fails in melanoma, page-12

First 12 Last

Share
Profile

Follow
Lopez

12,221 Posts.

1087

09/04/18

11:07

Post #: 32313733
Share

Originally posted by Shellbell ↑

Hi Davie I take on board wholeheartedly your opinion based on the fact you presented... the fact that the failed Incyte/Merck combo was a riskier punt. Well lets hope you are right that "VLA's long-term insto holders would be talking to Merck about whether the current offer is appropriate". An outcome from that is far more likely to be positive for the SP than shareholders knocking back the offer with a NO vote.

Given the info you shared (which is enlightening, btw), I still do not believe retail shareholders should have the attitude of voting NO to the offer (whether it be the current one or a counter one)... not that their votes will have much bearing. The worst case scenario for VLA shareholders is to end up back on the market... imo. I could be wrong, but would hate to have to test it.

Thanks, Davie, for your input. I have appreciated your insightful contributions over the years.

Expand

Hi,
something going on. IMO.
Aloha.

VLA Price at posting: $1.70 Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

IMR

Imricor raises $35M to pursue growth and expansion into Australia and NZ

GNX

NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project

Wealth Within considers potential takeover targets in Australia's booming infrastructure industry

MCT

Metalicity looking for offers on Admiral Bay zinc project

FG1

Flynn Gold flags mid-grade drill hits and always eye-catching rock chips

LKE

Lake Resources implies news article on job cuts made up; non-core sales "not material" and no rule 15.7 breach

Talking Australia's very competitive property landscape: Realty Talks

Warren Tredrea’s weekly sports business wrap: the latest on business in sport

Week 29 Wrap: Trump in spotlight again; China's Third Plenum a yawnfest; RBA's August move a mystery

AI stocks: What to expect in 2024-25

There are more pages in this discussion • 5 more messages in this thread...

First 12 Last

Add VLA (ASX) to my watchlist